Pipeline Updates: VulcanChem Provides Quality Compounds of Potential Cures for COVID-19 Research

PASADENA, Calif. - July 6, 2020 - PRLog -- Products Updates: VulcanChem Provides Quality Compounds of Potential Cures for COVID-19 Research

Over 10 million people worldwide have tested positive for the novel coronavirus and that number is quickly growing. Our healthcare system is becoming increasingly strained and we are in desperate need of a safe and effective treatment for COVID-19. Scientists around the world are racing against time to find a cure/drug. VulcanChem (California, USA) and its collaborating facilities are providing research-grade compounds of potential drugs to help to accelerate the ongoing research to find a cure.

Please note that the following items are for research use only. Not for human or veterinary use.

1) Remdesivir

2) Dexamethasone

3) Hydroxychloroquine and chloroquine

4) Azithromycin

5) Avigan (favipiravir)

6) Colcrys (colchicine)

7) Ivermectin

8) Tamiflu (oseltamivir)

There is no cure or vaccine for COVID-19 at this time. More studies are needed to confirm if any of the potential treatments listed above will work for COVID-19. Research on COVID-19 is rapidly evolving. For now, the treatment for patients with mild symptoms is to self-isolate at home. Patients who are hospitalized receive supportive care (such as oxygen), enroll in clinical trials, and are given medications off-label based on hospital guidelines and their doctors' clinical judgement.

For more information: https://www.vulcanchem.com/product/inhibitors/VC1031201
For more information: https://www.vulcanchem.com/product/inhibitors/259793-96-9